Literature DB >> 25825255

Extramedullary disease in multiple myeloma in the era of novel agents.

Joan Bladé1, Carlos Fernández de Larrea1, Laura Rosiñol1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25825255     DOI： 10.1111/bjh.13384

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Clinical relevance of PET/CT in patients with newly diagnosed multiple myeloma.

Authors:  Chaoyu Wang; Ling Wu; Chengtao Sun; Yizhuo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

Review 2.  Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.

Authors:  G Shay; L Hazlehurst; C C Lynch
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

3.  Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

Authors:  Valentina Marchica; Fabrizio Accardi; Paola Storti; Cristina Mancini; Eugenia Martella; Benedetta Dalla Palma; Marina Bolzoni; Katia Todoerti; Magda Marcatti; Chiara Schifano; Sabrina Bonomini; Gabriella Sammarelli; Antonino Neri; Maurilio Ponzoni; Franco Aversa; Nicola Giuliani
Journal:  Int J Hematol       Date:  2016-10-03       Impact factor: 2.490

4.  Bilateral breast plasmacytoma: a clinical case report.

Authors:  Thais Rodrigues da Cunha Fischer; Fabiana Higashi; Edvan de Queiroz Crusoe; Vania Tietsche de Moraes Hungria
Journal:  Rev Bras Hematol Hemoter       Date:  2016-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.